Sanofi and Alphabet’s Verily Team Up for Diabetes Research

Sep 14, 2016

Bloomberg

Sanofi and Alphabet Inc.’s life sciences division, Verily, announced their plan to invest about $500M in a joint venture to treat diabetes based on forecasts that patients with diabetes are on the rise.

The venture, Onduo, plans to combine devices, software and medicine, according to a statement Monday from Sanofi and Verily, previously known as Google Life Sciences, according to a Bloomberg article.

Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments